TENAX THERAPEUTICS, INC. 8-K

What Happened
Tenax Therapeutics, Inc. (TENX) announced its financial results for the quarter ended March 31, 2026 in a press release issued on May 12, 2026. The company filed an 8-K under Item 2.02 to disclose the results; the press release is attached as Exhibit 99.1 and is incorporated by reference.

Key Details

• Filing date: May 12, 2026; reported period: quarter ended March 31, 2026.
• Item reported: 2.02 (Results of Operations and Financial Condition).
• Exhibit included: Exhibit 99.1 — press release dated May 12, 2026.
• 8-K also includes the Inline XBRL cover page (Exhibit 104) per Item 9.01.

Why It Matters
This 8-K provides TENX’s latest quarterly earnings and financial condition disclosure — essential information for investors tracking revenue, expenses, cash position, and any operational updates. Investors should review the attached press release and the company’s subsequent filings for specific figures, trends, and any management commentary that could affect the stock’s outlook.